tiprankstipranks
XBiotech (XBIT)
NASDAQ:XBIT
US Market

XBiotech (XBIT) Technical Analysis

Compare
329 Followers

Technical Sentiment

Overall Consensus
Strong Sell
4Bullish
2Neutral
16Bearish
Technical Analysis Consensus
Neutral
4Bullish
2Neutral
4Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
XBiotech’s (XBIT) Moving Averages Convergence Divergence (MACD) indicator is -0.32, suggesting XBiotech is a Sell.
XBiotech’s (XBIT) 20-Day exponential moving average is 3.37, while XBiotech’s (XBIT) share price is $2.99, making it a Sell.
XBiotech’s (XBIT) 50-Day exponential moving average is 4.18, while XBiotech’s (XBIT) share price is $2.99, making it a Sell.

XBiotech (XBIT) Pivot Points

Feb 22, 2025, 05:07 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
2.92
2.97
3.05
3.10
3.18
3.23
3.31
Fibonacci
2.97
3.02
3.05
3.10
3.15
3.18
3.23
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

XBiotech (XBIT) Moving Averages

Feb 22, 2025, 05:07 PM
Period
Simple
Exponential
MA5
3.10Sell
3.09Sell
MA10
3.17Sell
3.17Sell
MA20
3.32Sell
3.37Sell
MA50
4.27Sell
4.18Sell
MA100
5.73Sell
5.11Sell
MA200
6.26Sell
5.93Sell
XBiotech’s (XBIT) 10-Day exponential moving average is 3.17, while XBiotech’s (XBIT) share price is $2.99, making it a Sell.
XBiotech’s (XBIT) 100-Day exponential moving average is 5.11, while XBiotech’s (XBIT) share price is $2.99, making it a Sell.
XBiotech’s (XBIT) stock price is $2.99 and XBiotech’s (XBIT) 50-day simple moving average is 4.27, creating a Sell signal.
XBiotech’s (XBIT) stock price is $2.99 and XBiotech’s (XBIT) 100-day simple moving average is 5.73, creating a Sell signal.
XBiotech’s (XBIT) stock price is $2.99 and XBiotech’s (XBIT) 200-day simple moving average is 6.26, creating a Sell signal.

XBiotech (XBIT) Technical Indicators

Feb 22, 2025, 05:07 PM
Name
Value
Implied Action
RSI (14)
31.97
Neutral
STOCH (9,6)
14.71
Buy
STOCHRSI (14)
8.59
Buy
MACD (12,26)
-0.32
Sell
ADX (14)
57.31
Sell
Williams %R
-100.00
Buy
CCI (14)
-114.85
Buy
ATR (14)
0.24
-
Ultimate Oscillator
33.26
Neutral
ROC
-13.58
Sell
XBiotech’s (XBIT) Relative Strength Index (RSI) is 31.97, creating a Neutral signal.
XBiotech’s (XBIT) Trend Strength Indicator (ADX) is 57.31, creating a Sell signal.
XBiotech’s (XBIT) Commodity Channel Index (CCI) is -114.85, creating a Buy signal.
XBiotech’s (XBIT) Price Rate of Change (ROC) is -13.58, creating a Sell signal.

FAQ

Is XBIT a Buy, Hold, or Sell?
Based on XBIT’s technical indicators, XBIT is a Strong Sell.
    What is XBIT’s RSI (14)?
    XBIT’s RSI (14) is 31.97, which suggests XBIT is a Neutral.
      What is XBIT’s MACD?
      XBIT’s MACD is -0.32, which suggests XBIT is a Sell.
        What is XBIT’s 5-day moving average?
        XBIT’s 5-day moving average is 3.10, which suggests XBIT is a Sell.
          What is XBIT’s 20-day moving average?
          XBIT 20-day moving average is 3.32, which suggests XBIT is a Sell.
            What is XBIT’s 50-day moving average?
            XBIT’s 50-day moving average is 4.27, which suggests XBIT is a Sell.
              What is XBIT’s 200-day moving average?
              XBIT’s 200-day moving average is 6.26, which suggests XBIT is a Sell.
                What is XBIT’s Williams % R (14)?
                XBIT’s Williams % R (14) is -100.00, which suggests XBIT is a Buy.
                  What is XBIT’s CCI (14)?
                  XBIT’s CCI (14) is -114.85, which suggests XBIT is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis